Researchers have identified a promising strategy for protecting the brain from Alzheimer’s-related damage without directly removing harmful tau proteins. Scientists discovered that blocking specific immune cell activity helped preserve neurons and reduce neurological damage in experimental studies. The findings could lead to a new generation of treatments focused on slowing cognitive decline and preserving brain function in patients affected by neurodegenerative diseases.
About the Author
